Cargando…
Assessment of Fermented Soybean Meal on Salmonella typhimurium Infection in Neonatal Turkey Poults
SIMPLE SUMMARY: Fermented soybean meal (FSBM) improved the performance of neonatal turkey poults, and these changes were associated with morphometric changes in the intestinal mucosa, as well as reduction of leaky gut, within turkeys challenged with Salmonella typhimurium (ST) in two experimental in...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601728/ https://www.ncbi.nlm.nih.gov/pubmed/33050635 http://dx.doi.org/10.3390/ani10101849 |
Sumario: | SIMPLE SUMMARY: Fermented soybean meal (FSBM) improved the performance of neonatal turkey poults, and these changes were associated with morphometric changes in the intestinal mucosa, as well as reduction of leaky gut, within turkeys challenged with Salmonella typhimurium (ST) in two experimental infective models. Although the two strains used for the fermentation process showed in vitro activity against ST, no significant effect was observed in vivo. Nevertheless, FSBM reduced the severity of the ST infection in the therapeutic model. The fermentation with different beneficial bacteria and different inclusion rates of FSBM requires further investigation. ABSTRACT: This study’s objective was to evaluate the effect of the fermented soybean meal (FSBM) on Salmonella typhimurium (ST) to turkey poults using two models of infection. In the prophylactic model, one-day-old turkeys were randomly allocated to one of four different groups (n = 30 turkeys/group): (1) Control group, (2) FSBM group, (3) Control group challenged with ST (Control + ST), and (4) FSBM group challenged with ST (FSBM + ST). On day 9 of age, all poults were orally challenged with 10(6) colony forming units (CFU) ST and 24 h post-inoculation, intestinal samples were collected to determine ST recovery and morphometric analysis. Blood samples were collected to evaluate serum fluorescein isothiocyanate-dextran (FITC-d). In the therapeutic model, a similar experimental design was used, but turkeys were orally gavaged 10(4) CFU ST on day 1, and samples were collected at day 7. FSBM improved performance and reduced leaky gut in both experimental infective models. In the prophylactic model, FSBB induced morphology changes in the mucosa. Although the strains (Lactobacillus salivarius and Bacillus licheniformis) used for the fermentation process showed in vitro activity against ST, no significant effect was observed in vivo. The fermentation with different beneficial bacteria and different inclusion rates of FSBM requires further investigation. |
---|